Entreprises
OneMedNet Expands Partnership with Atropos Health for Clinical Data Access
The Minneapolis-based firm secures a three-year subscription deal to provide Atropos Health with de-identified medical data from over 90 million patient journeys.
Swiss parliament approves online access to AHV and IV data by 2028
Both chambers of the Swiss parliament have approved a plan to allow insured individuals to access their AHV and IV data online starting in 2028. The move aims to streamline the process and reduce costs associated with manual data handling.
Upbound Group appoints Scott Young as COO and Dev Chakraborty to lead Brigit
Upbound Group created a COO role for Scott Young and named Dev Chakraborty senior vice president of Brigit, citing operational leadership as the firm expands its retail‑finance brands.
Winnipeg Blue Bombers roll out Clover’s integrated payment system at Princess Auto Stadium
The Canadian Football League team adopts Fiserv’s Clover platform to streamline in-stadium payments, expanding its coverage to six of nine venues in Canada.
NextNav Names Two Executives to Senior Leadership Roles
NextNav has appointed Marissa Mitrovich as VP of Government Affairs and Vijay Venkateswaran as Chief Business Development Officer, as the firm expands its growth strategy.
Envoy Medical adds Canadian and Hong Kong patents, total rises to 97
Envoy Medical Inc. announced the grant of a Canadian patent and a Hong Kong patent, expanding its global portfolio to 97 patents and 35 pending applications.
CitroTech Partners With Athena Intelligence on Wildfire Tech
The Colorado-based firm will integrate Athena's geospatial risk platform with its CitroSafe fire-inhibitor systems, initially targeting homes, utilities and insurers.
Mini Cooper SE Paul Smith Edition im Test: Elektro-Kleinwagen mit Designstatement
Der vollelektrische Mini Cooper SE in einer exklusiven Kollaboration mit Sir Paul Smith vereint urbritische Fashion mit moderner E-Mobilität — ein Stadtflitzer mit Charakter.
FDA approves Lantheus' BRAVNETSA for GEP-NETs
The FDA granted final approval to Lantheus Holdings' BRAVNETSA, a lutetium‑177 dotatate radioligand, deeming it bioequivalent to LUTATHERA for adult patients with somatostatin receptor‑positive gastroenteropancreatic neuroendocrine tumors.
Swvl launches 24/7 shuttle service in Madinah connecting seven hotels to holy site
The Nasdaq-listed ride-hailing operator says the round-the-clock service ties into its July partnership with Bank Albilad as it broadens beyond corporate and government clients in Saudi Arabia.
Vertex reports positive Phase 2b results for inaxaplin in kidney disease
The biotech firm said its experimental drug lowered protein markers in two small cohorts of patients with APOL1-mediated kidney disease, with no serious safety concerns.
FTI Consulting Hires Eileen Fargis as Senior Managing Director
The turnaround advisory firm adds a veteran energy and infrastructure executive to its Power, Renewables & Energy Transition practice in New York.
Annexon shares drop 6.7% as biotech presents vonoprument trial data at Cantor Fitzgerald
Annexon presented phase III ARCHER II trial enrollment figures and GBS program progress at the 12th Annual Cantor Fitzgerald Global Healthcare Conference on Thursday.
Crane NXT Sees Nearly Doubled Addressable Market, Targets $2.5 Billion Sales Path
The security technologies company, spun off from Crane Company in 2023, outlined its post-Antares Vision acquisition strategy at the Jefferies Global Industrials Conference, projecting a long-term sales trajectory toward $2.5 billion.
Nomad Compute Appoints Brian Stockbridge as Non-Executive Director
The AQSE-listed firm brings in an experienced corporate finance veteran; outgoing director Marc Dixon departs with no reasons given.
Beneficient Sets Q4 2026 Launch for Alternative Asset Analytics Platform
Dallas-based Beneficient plans to release AltLens, a portfolio analytics and risk tool targeting family offices and smaller institutions, in the fourth quarter of 2026.
Onex pivots to earnings story, cuts private equity exposure 19 percentage points
At Scotiabank's summit, Onex CEO Bobby Le Blanc outlined a strategic shift from NAV to earnings power, citing Convex's scale and a $1B valuation for remaining $5B in assets.
Orchestra BioMed at Wells Fargo: Partnership Model in Focus
Orchestra BioMed discusses its strategic partnerships and financial health at the Wells Fargo Healthcare Conference, highlighting its AVIM therapy and Virtue SAB products.
Stellantis Unveils FaSTLAne 2030 Recovery Plan Targeting 8-10% Operating Margin
CEO Antonio Filosa outlined a 60 billion-euro investment roadmap, $2.4 billion in 2027 cost savings, and commitments to positive free cash flow from 2027 onward.
Coinbase charts path beyond crypto at Citi TMT conference
Coinbase CFO Alesia Haas outlined plans to expand the platform into prediction markets, tokenized equities, and agentic payments, as the company pushes toward an "everything exchange."
Nuvation Bio highlights pipeline progress and cash strength at Cantor conference
CEO David and CFO Philip outlined IBTROZI's market potential, safusidenib data and a $700 million cash reserve, while the stock traded around $6.30.
Crescent Biopharma Outlines Global Trial Roadmap at Cantor Conference
The biotech said CR-001, a VEGF-PD-1 bispecific, targets 50%-70% response rates matching ivonescimab, with Phase I data due in early 2027 and global registration trials expected soon after.
ORIC Pharmaceuticals Highlights Pipeline Progress at Cantor Fitzgerald Healthcare Conference
Biotech CEO Jacob Chacko outlined Enosartib and rinzimetostat trial timelines while noting Pfizer's MEVPRO readout window and $388M cash runway through mid-2028.
Brenntag issues €500 million bond at 4.25% coupon
German chemical distributor Brenntag SE placed a €500 million seven‑year bond priced at 99.626% of face value, offering a 4.25% coupon for general corporate purposes.